Biomarker News and Research

RSS

A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.

Researchers find possible window of opportunity to target astrocyte abnormalities during ALS treatment

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder that affects as many as 30,000 people in the United States, with 5,000 new cases diagnosed each year. It weakens muscles over time, impacting physical function and ultimately leading to death.

29 Mar 2022

Depression occurs independently of inflammation for many older people, study suggests

Multiple prior studies have found higher levels of inflammation in older individuals with depression. Now, a new Penn Medicine study has found that clinically depressed older individuals, on average, don't have elevated levels of inflammation if they don't already have other inflammatory conditions such as arthritis.

28 Mar 2022

Biologists discover gene deletion behind abnormality in blood cancer cells

The mystery is being unraveled of why the control centers, or nuclei, of certain blood cancer cells have a distinctly odd shape.

27 Mar 2022

Computer algorithm predicts coronary artery disease-related events based on voice recordings

An artificial intelligence (AI)-based computer algorithm accurately predicted a person's likelihood of suffering heart problems related to clogged arteries based on voice recordings alone, in a study presented at the American College of Cardiology's 71st Annual Scientific Session.

24 Mar 2022

Blood biomarker may uniquely aid prediction of dementia in Mexican Americans

Blood levels of a biomarker called glial fibrillary acidic protein (GFAP) may uniquely aid prediction of dementia in Mexican Americans, researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and collaborating institutions reported March 24.

24 Mar 2022

Biomarker testing in lung cancer patients has increased in real-world clinical practice, study reveals

More than half of patients diagnosed with advanced non-small cell lung cancer (NSCLC) undergo biomarker testing, and this figure has increased over the last five years, reveal real-world data from a Spanish national registry study reported at the European Lung Cancer Congress, 30 March-2 April 2022.

23 Mar 2022

TTUHSC researcher secures $1.9 million grant to investigate vulnerabilities in ALT cancers

The National Cancer Institute, part of the National Institutes of Health, recently awarded a five-year, $ $1.9 million grant to C. Patrick Reynolds, M.D., Ph.D., director for the School of Medicine Cancer Center at the Texas Tech University Health Sciences Center.

23 Mar 2022

Daily consumption of cranberries for one month improves cardiovascular function

A new clinical trial found daily consumption of cranberries for one month improved cardiovascular function in healthy men.

22 Mar 2022

Study reveals novel tumor biomarker of aggressive cancers with poor prognosis

A study published in The Journal of Pathology reveals that many cancers that carry a poor prognosis express an altered form of human telomerase reverse transcriptase (hTERT), an enzyme that regulates the expression of multiple genes.

22 Mar 2022

NIH launches Molecular Characterization Initiative for pediatric tumors

In support of President Biden's Cancer Moonshot℠ goal of fostering data sharing in cancer research, the National Cancer Institute, part of the National Institutes of Health, has launched the Molecular Characterization Initiative for pediatric tumors.

21 Mar 2022

Novel device uses tiny worms to detect lung cancer cells

Dogs can use their incredible sense of smell to sniff out various forms of cancer in human breath, blood and urine samples.

20 Mar 2022

HRR mutational status associated with survival outcomes in recurrent platinum-sensitive ovarian cancer

Results of a biomarker analysis of the NRG Oncology NRG-GY004 trial were presented at a Seminal Session during the Society for Gynecologic Oncology's (SGO) Annual Meeting on Women's Cancer in March 2022.

19 Mar 2022

Biomarkers to identify SARS-CoV-2 patients requiring invasive mechanical ventilation

Researchers evaluated biomarkers that could help identify COVID-19 patients needing invasive mechanical ventilation.

17 Mar 2022

Lateral flow assays: The possibilities beyond COVID-19

In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences company) about the possibilities lateral flow assays offer in the post-covid healthscape.

From nanoComposix 17 Mar 2022

Accurate detection of D-dimer for pulmonary embolism among ER patients with suspected COVID-19

Researchers evaluate the diagnostic accuracy of an age-adjusted D-dimer strategy to predict PE diagnosis in patients with confirmed or suspected COVID-19.

16 Mar 2022

Epigenetic changes could be a biomarker for early detection of type 1 diabetes

Children who develop type 1 diabetes show epigenetic changes in the cells of their immune system already before the antibodies of the disease are detected in their blood.

16 Mar 2022

Serum folate deficiency in older people may be associated with heightened dementia and death risks

Low levels of folate (vitamin B9) in the blood may be linked to a heightened risk of dementia and death from any cause in older people, suggests research published online in the journal Evidence Based Mental Health.

16 Mar 2022

Can cardiac biomarkers determine COVID-19 prognosis?

Researchers review prognostic cardiac biomarkers in COVID-19 patients.

15 Mar 2022

Study reveals the oncometabolite role of progesterone in advanced prostate cancer

In a study published in Cell Reports Medicine, a group of Chinese scientists revealed the oncometabolite role of progesterone in advanced prostate cancer and strategies to eliminate its oncogenic effect as an aspect of prostate cancer treatment.

15 Mar 2022

Research findings may explain marked racial disparity in deaths from triple negative breast cancer

Different activity in two molecular networks could help explain why triple negative breast cancers tend to be more aggressive in African American (AA) women compared with white American (WA) women, a new study led by Johns Hopkins Kimmel Cancer Center researchers suggests.

15 Mar 2022

Biomarker News and Research

Further Reading

Researchers find possible window of opportunity to target astrocyte abnormalities during ALS treatment

Depression occurs independently of inflammation for many older people, study suggests

Biologists discover gene deletion behind abnormality in blood cancer cells

Computer algorithm predicts coronary artery disease-related events based on voice recordings

Blood biomarker may uniquely aid prediction of dementia in Mexican Americans

Biomarker testing in lung cancer patients has increased in real-world clinical practice, study reveals

TTUHSC researcher secures $1.9 million grant to investigate vulnerabilities in ALT cancers

Daily consumption of cranberries for one month improves cardiovascular function

Study reveals novel tumor biomarker of aggressive cancers with poor prognosis

NIH launches Molecular Characterization Initiative for pediatric tumors

Novel device uses tiny worms to detect lung cancer cells

HRR mutational status associated with survival outcomes in recurrent platinum-sensitive ovarian cancer

Biomarkers to identify SARS-CoV-2 patients requiring invasive mechanical ventilation

Lateral flow assays: The possibilities beyond COVID-19

Accurate detection of D-dimer for pulmonary embolism among ER patients with suspected COVID-19

Epigenetic changes could be a biomarker for early detection of type 1 diabetes

Serum folate deficiency in older people may be associated with heightened dementia and death risks

Can cardiac biomarkers determine COVID-19 prognosis?

Study reveals the oncometabolite role of progesterone in advanced prostate cancer

Research findings may explain marked racial disparity in deaths from triple negative breast cancer

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo